Clinical trial
HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy
NCT00181506 · Maastricht Radiation Oncology, Other · Completed
Key facts
| NCT number | NCT00181506 |
|---|---|
| Title | HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy |
| Official title | HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Accelerated Conformal Radiotherapy in Patients With Inoperable Non-Small Cell Lung Cancer. |
| Lead sponsor | Maastricht Radiation Oncology, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small-Cell Lung Carcinoma |
| Intervention type | Procedure |
| Interventions | dose escalation (radiotherapy treatment schedule) |
| Enrollment | 180 |
| Start date | Dec 1, 2001 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 30, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: